What is the main purpose of this 8-K/A filing?

The main purpose of this amendment (8-K/A) is to disclose the appointment of Carla A. Hills to the Nominating and Corporate Governance Committee of Gilead Sciences' Board of Directors. This is a follow-up to her initial appointment to the Board in January 2007.

Who is Carla A. Hills and why is her committee appointment significant?

Carla A. Hills is a member of Gilead Sciences' Board of Directors. Her appointment to the Nominating and Corporate Governance Committee is significant as this committee is responsible for identifying and recommending director nominees and overseeing corporate governance policies, which are key areas for investor confidence and company oversight.

When did this committee appointment officially take place?

The Board of Directors appointed Ms. Hills to the Nominating and Corporate Governance Committee on May 8, 2007.

Is this a new event or an amendment to previous information?

This is an amendment to a previous Form 8-K filing. It amends information originally filed in January 2007 and February 2007 by providing an update on Ms. Hills' committee assignments, which were not determined at the time of her initial board appointment.

GILD 8-K: Leadership Changes

Summary

This filing is an amendment to a prior Form 8-K, specifically addressing an update to committee assignments for a recently appointed director. The key information for investors is that Carla A. Hills, who was appointed to Gilead Sciences' Board of Directors in January 2007, has now been appointed to serve on the Nominating and Corporate Governance Committee of the Board. This clarifies her role and responsibilities within the board structure. While this amendment is procedural, it confirms board committee assignments which are important for understanding corporate governance and oversight. Investors can view this as a confirmation of established board processes and a step towards fully integrating new directors into the company's governance framework.

Key Highlights

1Amendment to a previous Form 8-K filing.
2Carla A. Hills appointed to the Nominating and Corporate Governance Committee of the Board of Directors.
3This appointment occurred on May 8, 2007.
4Ms. Hills was initially appointed to the Board of Directors on January 22, 2007.
5The filing clarifies board committee assignments after her initial appointment.
6The report was filed on May 9, 2007.

GILEAD SCIENCES, INC. 8-K/A Report, Executive Changes (May 10, 2007)

Summary

Key Highlights

Frequently Asked Questions